Skip to content
  • Home
  • Product
  • History
  • Publications
  • News
  • Contact
Menu
  • Home
  • Product
  • History
  • Publications
  • News
  • Contact
  • EN
  • TH
  • EN
  • TH

Publications

2007

1

Separation of intact Plasmalogens and all other phospholipids by a single
run of high-performance liquid chromatography

Sience Direct

2012

2

3

4

Anti-inflammatory/anti-amyloidogenic effects of plasmalogens in
lipopolysaccharide-induced neuroinflammation in adult mice

Changes in Phospholipid Composition of Erythrocyte Membrane in
Alzheimer’s Disease

Dietary Plasmalogen increases erythrocyte membrane plasmalogen in rats

Journal of
Neuroinflammation

Dementia and Gerlatric
Cognitive Disorders

Lipids in Health
and Disease

2015

5

Mortality Benefit of Participation in BOOCS Program, A Follow-Up Study
for 15 Years in a Japanese Working Population

American College of Occupational and Environmental Medicine

2016

6

Measurement of Ether Phospholipids in Human Plasma with HPLC-ELSD
and LC/ESI-MS After Hydrolysis of Plasma with Phospholipase A

Springer AOCS

2017

7

8

Efficacy and Blood Plasmalogen Chages by Oral Administration of
Plasmalogen in Patients with Mild Alzheimer’s Disease and Mild Cognitive
Impairment : A Multicenter,Randomized,Double-blind,Placebo-controlled Trial

Plasma and Erythrocyte Membrane Plasmalogen Diminished in Severe
Atheroscleroic Patients Underging Endovascular Therapy

EBioMedicine
MEMBRANE

2018

9

Effects of Plasmalogen on Patients with Mild Cognitive Impairment:
A Randomized,Placebo-Controlled Trial in Japan

Journal of Alzheimer’s Disease & Parkinsonism

2019

10

Effects of Plasmalogen on Patients with Moderate-to-Severe Alzheimer’s
disease and Blood Plasmalogen Changes: A Multi-Center,Open-Label Study

Journal of Alzheimer’s Disease & Parkinsonism

2020

11

12

Identification of Plasmalogens in Bifidobacterium longum,but not in
Bifidobacterium animalis

Improvement of Blood Plasmalogens and Clinical Syptoms in Parkinson’s
Disease by Oral Administration of Ether Phospholipids: A Preliminary Report

Nature Scientific Reports
Hindawari Parkinson’s Disease

缩醛磷脂对轻度认知障碍患者的影响:日本的一项随机,安慰剂对照试验

Effects of Plasmalogen on Patients with Mild Cognitive Impairment: A Randomized,Placebo-Controlled Trial in Japan

缩醛磷脂对中度至重度阿尔茨海默氏病和缩醛磷脂变化患者的影响:多中心,开放标签研究

« Previous Page1 Page2 Page3 Page4 Page5 Next »

缩醛磷脂对中度至重度阿尔茨海默氏病和缩醛磷脂变化患者的影响:多中心,开放标签研究

Effects of Plasmalogen on Patients with Moderate-to-Severe Alzheimer’s disease and Blood Plasmalogen Changes: A Multi-Center,Open-Label Study

确认长双歧杆菌中的缩醛磷脂,但是不是动物双歧杆菌中

Improvement of Blood Plasmalogens and Clinical Syptoms in Parkinson’s Disease by Oral Administration of Ether Phospholipids: A Preliminary Report

« Previous Page1 Page2 Page3 Page4 Page5 Next »
  • Home
  • Product
  • History
  • Publications
  • News
  • Contact
  • Home
  • Product
  • History
  • Publications
  • News
  • Contact
Cleantalk Pixel